Optimizing Phase Ib with the right partner

As clinical development evolves to enhance solutions for sponsors, the demand for hybrid designs in studies requiring early patient data continues to grow. While there are many benefits to running hybrid protocols, there are several challenges that must also be mitigated. A strong partner who understands those challenges can make all the difference in advancing studies safely and with optimal cost and time efficiencies.